Murali Janakiram, M.D.
Department of Microbiology & Immunology
Albert Einstein College of Medicine
Forchheimer Building, Room 405
Bronx, NY 10461
Murali Janakiram received his MBBS degree from Madras Medical College in India. He then moved to England where he worked as a Senior House Officer in various subspecialties of Medicine under the University of Liverpool. He did his Internal Medicine residency between 2007 to 2010 at Metro Health Medical Center, Case Western School of Medicine. After his residency, he then joined the Hematology/Oncology fellowship program at the Albert Einstein College of Medicine. He is currently enrolled in the Masters in Clinical Research program at the Albert Einstein College of Medicine. His research interests include investigating the expression and role of coinhibitory B7 molecules (PD-L1, B7x and B7H3) in human breast cancer and clinical trials of cancer immunotherapy.
Janakiram M, Abadi YM, Sparano JA, Zang X. T cell coinhibition and immunotherapy in human breast cancer. Discovery Medicine, 14:229-236, 2012
Janakiram M, Thirukonda VK, Sullivan M, Petrich AM. Emerging therapeutic targets in diffuse large B-cell lymphoma. Current Treatment Options in Oncology, 13: 82-101, 2012
Ayyappan S, Janakiram M, Raghupathy R. Current and emerging therapies in primary myelofibrosis. Cardiovascular & Hematological Disorders-Drug Targets, 12:6-20, 2012
Antonelli M, Bupathi M, Janakiram M, Hergenroeder P, Khan MA. Acquired erythrocytosis upon treatment with infliximab for ankylosing spondylitis. The Journal of Rheumatology, 38: 581-583, 2011
Saravanan V, Janakiram M, Bankar RN, Kumar S, Nasar A. An unusual cause of paraplegia. British Journal of Hospital Medicine, 67:97, 2006